These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 14696943

  • 1. Pharmacological strategies in treatment-resistant depression.
    Alao AO, Malhotra K, Pies R, Dewan MJ.
    West Afr J Med; 2003 Sep; 22(3):211-8. PubMed ID: 14696943
    [Abstract] [Full Text] [Related]

  • 2. Switching antidepressants for treatment-resistant major depression.
    Marangell LB.
    J Clin Psychiatry; 2001 Sep; 62 Suppl 18():12-7. PubMed ID: 11575730
    [Abstract] [Full Text] [Related]

  • 3. Combining antidepressants for treatment-resistant depression: a review.
    Lam RW, Wan DD, Cohen NL, Kennedy SH.
    J Clin Psychiatry; 2002 Aug; 63(8):685-93. PubMed ID: 12197448
    [Abstract] [Full Text] [Related]

  • 4. Rational drug use in the treatment of depression.
    Cohen LJ.
    Pharmacotherapy; 1997 Aug; 17(1):45-61. PubMed ID: 9017765
    [Abstract] [Full Text] [Related]

  • 5. Augmentation and combination strategies in treatment-resistant depression.
    Fava M.
    J Clin Psychiatry; 2001 Aug; 62 Suppl 18():4-11. PubMed ID: 11575733
    [Abstract] [Full Text] [Related]

  • 6. Cardiac disorders and antidepressant medications.
    Murray JB.
    J Psychol; 2000 Mar; 134(2):162-8. PubMed ID: 10766108
    [Abstract] [Full Text] [Related]

  • 7. Management of nonresponse and intolerance: switching strategies.
    Fava M.
    J Clin Psychiatry; 2000 Mar; 61 Suppl 2():10-2. PubMed ID: 10714618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Switching drug class after initial SSRI failure.
    Kelsey JE.
    J Clin Psychiatry; 1997 Jul; 58(7):326-7. PubMed ID: 9269258
    [No Abstract] [Full Text] [Related]

  • 10. [Antidepressant and tolerance: Determinants and management of major side effects].
    David DJ, Gourion D.
    Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Re: A time to bury tricyclic antidepressants or to praise them?
    Berber MJ.
    Can J Psychiatry; 1997 Aug; 42(6):663. PubMed ID: 9288430
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extrapyramidal symptoms associated with cyclic antidepressant treatment: a review of the literature and consolidating hypotheses.
    Gill HS, DeVane CL, Risch SC.
    J Clin Psychopharmacol; 1997 Oct; 17(5):377-89. PubMed ID: 9315989
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined MAOI-tricyclic antidepressant treatment: a reevaluation.
    White K, Simpson G.
    J Clin Psychopharmacol; 1981 Sep; 1(5):264-82. PubMed ID: 7037873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment algorithms in treatment-resistant depression.
    Amsterdam JD, Hornig-Rohan M.
    Psychiatr Clin North Am; 1996 Jun; 19(2):371-86. PubMed ID: 8827195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.